Progress
CanCOGeN update
Updated: April 2022
0
Viral samples sequenced
0
Host samples sequenced
VirusSeq update (April 2022)
SARS-CoV-2 genomes sequenced
|
Sequenced and shared with public health authorities
|
New sequences since April 8
|
Cumulative sequences to date
|
Sequences uploaded to GISAID
|
Sequences uploaded to VirusSeq Data Portal
|
|---|---|---|---|---|
|
Alberta
|
501
|
59,960
|
43,785
|
44,609
|
|
British Columbia
|
|
157,016
|
125,108
|
101,690
|
|
Manitoba
|
184
|
10, 525
|
6,232
|
3,158
|
|
New Brunswick
|
189
|
6,581
|
5,149
|
3,935
|
|
Newfoundland and Labrador
|
44
|
1,794
|
1,215
|
1,199
|
|
Nova Scotia
|
212
|
3,979
|
3,193
|
2,720
|
|
Ontario
|
1,632
|
85,064
|
68,759
|
55,296
|
|
Prince Edward Island
|
21
|
600
|
|
|
|
Quebec
|
1,173
|
77,191
|
38,912
|
35,352
|
|
Saskatchewan
|
380
|
30,765
|
22,274
|
17,311
|
|
Total
|
4,336
|
433,475
|
314,627
|
265,270
|
HostSeq update (April 2022)
COVID-related clinical studies being recruited into HostSeq:
0
N.L
N.S.
Que.
Ont.
Man.
Sask.
Alta.
B.C.
This table represent the total number (23) of investigator/clinician led studies across Canada with COVID-affected individuals that have confirmed participation in HostSeq:
|
Onboarding
|
Actively Sequencing
|
Samples committed
|
Host sequences completed
|
Clinical data secured
|
|---|---|---|---|---|
|
10
|
13
|
13, 888
|
7,171
|
6,110
|
